Reference Value. Equity as reported in the selected filing.
EstPharma OÜ - Company Valuation
Reported Book Equity
0 €
Reference Value
- Based on FY
- 2025
- Valuation Date
- Business StrengthSummarises business strength from financial and public-record signals. Learn More ↗ Opens in a New Tab
- F
- Risks
- Negative EquityDistressedLoss-Making
Scope & Evidence
- Company
- EstPharma OÜ
- Registration
- EE · 14915921
- Covers
- Single Company
- Filings Used
- 6 · FY 2025, 2024, 2023, 2022, 2021, 2020
Key Ratios
- Current RatioCurrent assets divided by current liabilities. Learn More ↗ Opens in a New Tab
- 0.61×
- Quick RatioCurrent assets minus inventory, divided by current liabilities. Learn More ↗ Opens in a New Tab
- -
- Debt / EquityTotal liabilities divided by equity. Learn More ↗ Opens in a New Tab
- -
- Equity RatioEquity as a share of total assets. Learn More ↗ Opens in a New Tab
- -63.6%
- Interest CoverageEBIT divided by interest expense. Learn More ↗ Opens in a New Tab
- -
- Gross MarginGross profit as a share of revenue. Learn More ↗ Opens in a New Tab
- -
- Net Profit MarginNet profit as a share of revenue. Learn More ↗ Opens in a New Tab
- -5.0%
- Return on EquityNet profit as a share of owners' equity. Learn More ↗ Opens in a New Tab
- -
- Return on AssetsNet profit as a share of total assets. Learn More ↗ Opens in a New Tab
- -35.6%
- Revenue CAGRAverage annual revenue growth over the available period. Learn More ↗ Opens in a New Tab
- 14.6%
Liability Maturity
Short-Term
3-Year Revenue Scenarios
12m €
9m €
6m €
3m €
0 €
202620272028
OptimisticBaseConservative
A comparison between a company and a defined peer group. Learn More ↗ Opens in a New Tab
Revenue vs Industry Peers
- Aaloe Apteegid OÜ
- 25,205,241 €
- osaühing TARTU UUSAPTEEK
- 21,012,136 €
- Eyrekodu OÜ
- 6,819,467 €
- Farmalpluss OÜ
- 6,713,301 €
- EstPharma OÜ ★
- 5,282,539 €
- Farmaking OÜ
- 2,814,570 €
Earnings before interest, taxes, depreciation, and amortisation. Learn More ↗ Opens in a New Tab
Revenue, Profit & EBITDA
6m €
4m €
2m €
0 €
-2m €
20212022202320242025
RevenueNet Profit
Versus Industry Median
6m €
4m €
2m €
0 €
-2m €
RevenueNet Profit
This CompanyIndustry Median